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Abstract
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Graphical abstract

Syntheses of three new chlorin e6 conjugates for PDT of tumors are reported. One of the new
compounds 17 is conjugated with lysine at the 131-position, but the others are mono-conjugated
14 or diconjugated 15 with the non-amino acid species ethanolamine. Cellular experiments with
the three new compounds and previously synthesized non-amino acid 152-conjugates (7–10), 131monoconjugates 14, 16, and a 131,152-diconjugate 12 are reported. In vitro cytotoxicity
experiments show that the 131-conjugates are more toxic than the 152-conjugates, and the most
toxic derivative (dark- and photo-toxicity) is the 131-ethylenediamine conjugate 11. The most
useful PDT photosentitizers appear to be the ethanolamine derivatives, conjugated at the 152- and
the 131,152-positions; these show high phototoxicity but relatively low dark toxicity compared
with 11, and also the highest dark/photo cytotoxicity ratios.
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INTRODUCTION
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Photodynamic therapy (PDT) depends upon the selective uptake of a photosensitizer into
tumor tissues, followed by production of singlet oxygen or other toxic species upon
irradiation with light of a wavelength that can be absorbed by the sensitizer [1–3]. A firstgeneration FDA-approved sensitizer, Photofrin® (porfimer sodium), has been developed
commercially and used in more than 40 countries. This photosensitizer suffers from issues
associated with minimal absorption of light within the preferred “therapeutic window” (600–
850 nm) and its prolonged retention in skin tissue, causing patient photosensitivity that can
last for weeks [4]. New, so-called “second generation” photosensitizers, such as mono-(L)aspartylchlorin e6, (NPe6, Talaporfin, LS-11) have more recently been used in PDT clinical
trials. NPe6 is prepared from the tricarboxylic acid chlorin e6 (1) by treatment with aspartic
acid salts in the presence of a base and a standard peptide coupling agent (e.g. DCC). NPe6
possesses a typical chlorin-type absorption spectrum with λmax at about 660 nm; studies
show that, upon irradiation, it can produce cytotoxic singlet oxygen in high yields.
Compared with Photofrin, it also clears rapidly from normal tissues [4, 5].

Author Manuscript

Chlorin e6 (1) (Chart 1) possesses three chemically distinct carboxylic acid functions that
can be used for selective conjugation purposes. These are a formic carboxylate substituent at
position-13, an acetic carboxylate at position-15, and a longer chain propionate substituent
at position-17. The NPe6 patent identifies this amino acid conjugate as the 173-aspartyl
derivative of chlorin e6 (2) [6]. In 1998 a study primarily involving 2D NMR spectroscopy
claimed that NPe6 is in fact the 152-regioisomer 3 of chlorin e6 (1) [7]. This revelation was
largely ignored, possibly because the 15-acetic side chain appeared to be of reduced
reactivity toward amidation compared with the unhindered and more aliphatic propionic side
chain at position-17. Conjugations with chlorin e6 continued to be reported as taking place at
the 17-position. At this point, our group reported the unambiguous syntheses of the three
regioisomers 2–4 of NPe6, as their easily purified and fully characterized tetramethyl esters.
This work showed conclusively that NPe6 is indeed the 152-regioisomer 3 [8], as proposed
by Gomi et al. [7]. A variety of other conjugations were also shown to occur preferentially at
the 152 position [9], and an X-ray structure of the tetramethyl ester prepared from authentic
commercial NPe6, definitively placed the aspartic acid residue at the 152 position [8].
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A hypothesis was advanced [8] that the 131: 152-anhydride 5 of chlorin e6 was a key
intermediate in the aspartic acid conjugation reaction, produced by a DCC-mediated
dehydration reaction between the 131 and 152 carboxylic acids prior to involvement of the
aspartic acid; subsequent reaction of the nucleophilic amino acid at the more electrophilic
and reactive aliphatic 152-carbonyl rather than the aromatic 131-nuclear carbonyl of the
anhydride affords the conjugate 3. More recently, we have definitively identified the
anhydride 5 as the critical intermediate that controls the regiochemistry of the overall
reaction [12]; this was done by isolation and full characterization of the methyl ester 6 of
anhydride 5, as well as by reporting a single crystal X-ray structure of 6.
The differential reactivity of the three carboxylate side chains in chlorin e6 (1) was exploited
by syntheses and cellular investigations of 173-, 152- and 131-conjugates with aspartic acid
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and lysine [9]. The three different regioisomers were synthesized in good yields.
Experiments using human carcinoma HEp2 cells showed that the 152-lysyl regioisomers
accumulated best within cells, but the most phototoxic conjugates were the 131-conjugates.
The main factor influencing the biological activity of any individual compound appeared to
be the amino acid conjugation site, with the 173-conjugates (identified in the patent [6] as
being the structure of, for example, NPe6) being the least active sensitizers. These studies
were followed up with new syntheses and cellular studies of di-aspartate and aspartate-lysine
chlorin e6 conjugates [13]. Regioselective synthetic procedures to four chlorin e6 bis(amino
acid) conjugates were developed for bis-conjugates bearing two aspartate residues in the
131,173- and 152,173-positions, as well as at the 131,152 sites connected via an ethylene
diamine insert. A fourth conjugate featuring two different amino acids, namely lysine at 131
through an ethylene diamine linker and an aspartate residue at 152 through a β-alanine linker
was also synthesized. The dark- and photo-cytotoxicity and uptake of these four bis(amino
acid) chlorin e6 conjugates as well as chlorin e6 itself were measured using human HEp2
cells. The best conjugates were the 131,152-disubstituted conjugates, which were shown to
be well taken up and which also localized in multiple organelles. In comparison, any bisconjugate bearing an amino acid at position 173 (i.e. the 131,173-and 152,173-di-aspartyl
conjugates) showed low dark cytoxicity but lower phototoxicity properties compared with
chlorin e6 itself. Indeed, all of the bis-conjugates synthesized were inferior as PDT
sensitizers compared with the corresponding mono-conjugates [13].
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Our attention therefore moved back toward mono-conjugates of chlorin e6. In particular, four
non-amino acid 152-conjugates (7–10) of chlorin e6 were synthesized [12], as well as a bisconjuate with ethylenediamine [13]. In the present paper we report the syntheses of three
additional mono-conjugates and of one bis-conjugate (for comparison purposes), and also
report the results of cellular studies designed to assess their potential as effective PDT
agents.

RESULTS AND DISCUSSION
Selection and syntheses of non-amino acid monoconjugates
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Four non-amino acid 152-mono-conjugated chlorin e6 derivatives 7–10 [12], one 131conjugate 11 and one 131,152-bis-conjugate 12 [9] that had previously been reported were
selected for cellular investigations; these syntheses were accomplished using the anhydride 6
as an intermediate for 7–10, or from methyl pheophorbide a (13) for 11 and 12 (Scheme 2).
Initial in vitro biological evaluations of these compounds indicated that the 152ethanolamine conjugate 10 was particularly promising, and based on our earlier conclusions
that 131-conjugates are significantly more PDT-active than the 152-conjugates, we also
proceded to synthesize the analogous 131-ethanolamine conjugate 14. This compound, 14,
was obtained in 48% yield by ring-opening of methyl pheophorbide a (13) with 18
equivalents of ethanolamine in anhydrous ethyl acetate at room temperature for 24 h
(Scheme 2).
Finally, for completeness and to correlate results with the bis-conjugated derivatives reported
earlier, the 131,152-bis-ethanolamine conjugate 15 was also synthesized (Scheme 3). This
bis-conjugate was synthesized by firstly treating methyl pheophorbide a (13) with 1.5
J Porphyr Phthalocyanines. Author manuscript; available in PMC 2017 October 18.
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equivalents of ethanolamine in refluxing toluene, until TLC indicated disappearance of the
starting material, to give N-(2-hydroxyethyl)-acetamide pheophorbide a (16) in 82% yield.
Then excess ethanolamine (5.0 equivalents) was added with stirring for 19 h at 40 °C to
accomplish cleavage of the isocyclic ring and provide the 131,152-(2hydroxylethyl)amide-173-methyl ester chlorin e6 (15) in 47% yield (Scheme 3).
Synthesis of 131-lysylchlorin e6 trimethyl ester (17)

Author Manuscript

Our previous monoconjugation syntheses and cellular experiments [9] did not include a lysyl
mono-conjugate 17 in which the lysyl residue was directly attached to the chlorin e6 core; in
the previously reported 131-lysyl conjugate [9] the lysine was attached via an ethylene
diamine spacer. An attempt was made to synthesize the proposed chlorin e6 derivative using
the one-step nucleophilic attack of either of the lysine differentially mono-protected
nitrogens upon the 131-carbonyl of methyl pheophorbide a [14]. This procedure failed to
yield a useful product under a variety of solvent conditions. We therefore turned our
attention to a route (Scheme 4) involving amino acid coupling to the 131-carboxylic acid
function in 18. The dimethyl ester 18 was prepared by treatment of chlorin e6 (1) with
methanol in sulfuric acid; under these acidic conditions [8] the imine nitrogens of chlorin e6
(1) are protonated, thereby inactivating the electronically conjugated 131-carboxyl group
toward protonation, a key step in the esterification process. A quantitative yield of 18 was
obtained. Treatment of 18 with Boc-protected lysine methyl ester hydrochloride in presence
of HOBt and TBTU [9] gave 131-mono-(Boc)lysyl-chlorin e6 trimethyl ester (19), and this
was deprotected with TFA to give 131-mono-lysylchlorin e6 trimethyl ester (17), in a yield
of 33% from chlorin e6 (1).
Cellular studies
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Cytotoxicity—The dark and phototoxicity (~1.5 J/cm2 light dose) of chlorin e6 (1) and its
derivatives were evaluated in human carcinoma HEp2 cells using a CellTiter Blue assay, up
to 100 μM concentrations. The results obtained are shown in Table 1 and Figs S1 and S2 of
the Supporting information. It is clear from our results that the 152-substituted conjugates
have much lower dark cytotoxicity (IC50 > 100 μM) compared with the conjugates bearing a
substituent on the 131-position. The 131-ethylenediamine, 131-ethanolamine, and the 131lysine conjugates 11, 14 and 17, showed the highest dark cytotoxicity, with calculated IC50
values of 7, 36 and 34 μM, respectively (Table 1). The 131,152-disubstituted conjugates 12
and 15 were also found to be moderately cytotoxic with IC50 values of 45 and 59 μM,
respectively. Upon exposure to a low light dose (~1.5 J/cm2) the most phototoxic dyes were
generally again the 131-substituted conjugates, particularly the cationic 131ethylenediamine-chlorin e6 11 with a calculated IC50 value of 0.23 μM, followed by the 131ethanolamine, 131-lysine, and 131,152-bis-ethanolamine conjugates 14, 15, and 17. For
example, the substitution at the 152-position vs. the 131-position with an ethanolamine
group, as in 10 and 14, resulted in a 2–3 fold decrease in both dark and phototoxicity. On the
other hand, the introduction of hydrophobic groups at the 152-position of chlorin e6 further
lowers the phototoxicity, particularly for the 152-benzyl derivative 7, which showed the
lowest phototoxicity of all compounds in this series, even lower than that for chlorin e6 (1).
These results are in agreement with our previous observations on the dark/photo cytotoxicity
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of chlorin e6 amino acid derivatives, showing that the 131-substituted conjugates are in
general the most cytotoxic [13]. This could in part be due to the preferentially linear
molecular conformations of the 131-derivatives, which might facilitate interactions and
binding to biological substrates that enhance their cytotoxicity. On the other hand, the
cationic derivatives 11, 12 and 17 all showed high cytotoxicity; for example, the substitution
with an ethylenediamine group at the 131-position (as in 11) with ethanolamine (as in 14)
also resulted in a 2–5 fold decrease in both dark and phototoxicity. The combination of high
dark/photo cytotoxicity ratio, resulting from relatively low dark cytotoxicity but potent
phototoxicity, observed for the 152-ethanolamine and the 131,152-bis-ethanolamine
conjugates 10 and 15 makes them the most promising compounds for PDT among this
series. Although the 131-substituted derivatives 11, 14 and 17 show high phototoxicity, their
high dark cytotoxicies decrease their usefulness as PDT agents (see SI).
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Time-dependent cellular uptake—The results obtained for the time-dependent uptake
of chlorin e6 1 and six of its derivatives, including the most promising photosensitizers 10
and 15, at a concentration of 10 μM in human HEp2 cells are shown in Fig. 1. All derivatives
accumulated within cells to a larger extent than chlorin e6, (1), at all time points investigated.
The ethanolamine substituted derivatives 10, 14 and 15 accumulated the fastest in the first 1–
2 h, after which a plateau was reached and slower uptake was observed at times > 4 h,
particularly for 14 and 15. At 24 h the propyl derivative 8 showed the highest cellular
uptake, about 20-fold that of chlorin e6, followed by 9 and 10 (1- and 14-fold, respectively),
indicating that these 152-substituted derivatives are efficiently taken up by cells. The 131ethanolamine and 131,152-bis-ethanolamine derivatives 14 and 15 accumulated rapidly at
short times and at 24 h showed about 12- and 8-fold higher uptake than chlorin e6. These
results indicate that the mono-substituted chlorin e6 derivatives are more efficiently taken up
by cells compared with the di-substituted derivatives. The benzyl ester derivative 7 showed
the lowest uptake at 24 h, although still about 4-fold higher than for chlorin e6.
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Figure 2 shows the fluorescence of select chlorin e6 derivatives in HEp2 cells after 6 h
incubation. All compounds efficiently accumulated within the cells in multiple organelles,
including the lysosomes and the Golgi apparatus, as previously observed for amino acid
derivatives of chlorin e6 [13]. In addition, the 131-substituted compounds 11 and 12 appear
to localize to a small extent in cell mitochondria, and this might be one of the causes of the
observed higher dark and phototoxicities for these derivatives.

EXPERIMENTAL
General
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All air and moisture sensitive reactions were performed in dried and distilled solvents under
an argon atmosphere. All solvents and reagents were purchased from commercial sources,
unless otherwise stated. Silica gel 60 (230 × 400 mesh, Sorbent Technologies) was used for
column chromatography. Analytical thin-layer chromatography (TLC) was carried out using
polyester backed TLC plates 254 (precoated, 200 μm) from Sorbent Technologies. NMR
spectra were recorded on an AV-400 spectrometer (400 MHz for 1H, 100 MHz for 13C). The
chemical shifts are reported in δ ppm using the following partially deuterated solvents as

J Porphyr Phthalocyanines. Author manuscript; available in PMC 2017 October 18.

Chen et al.

Page 6

Author Manuscript

internal references: CD2Cl2 5.32 ppm (1H), 54 ppm (13C); d-DMSO 2.49 ppm (1H), 39.5
ppm (13C); d-CH3OH 4.78 ppm (1H), 49.0 ppm (13C); CDCl3 7.26 ppm (1H), 77.16 ppm
(13C); (CH3)2CO 2.50 ppm (1H), 29.84 ppm (13C). Electronic absorption spectra were
measured on an Agilent 8453 UV-vis spectrophotometer. Mass spectra were obtained on a
Bruker Omniflex MALDI Time-of-Flight Mass Spectrometer. All compounds synthesized
were purified and isolated in ≥95% purity, as evidenced by analytical TLC in at least two
solvent systems, and confirmed by the absence of extraneous tetrapyrrole resonances in 1Hand 13C-NMR spectra. Conjugates 7–10 [12], 11 [9] and 12 [13] were prepared according to
appropriate literature procedures and were authenticated by comparison with the literature
data.
Synthetic procedures

Author Manuscript
Author Manuscript

131-(2-Hydroxyethyl)amide-152,173-dimethyl ester chlorin e6 (14)—Methyl
pheophorbide a (13) (50 mg, 0.082 mmol) was dissolved in dry EtOAc (3 mL) and stirred
under argon for 10 min. Then 0.091 mL of ethanolamine (0.091 mL, 1.510 mmol, 25.0
equiv.) was added to the solution and the mixture was stirred for 24 h. The reaction was
monitored by UV-vis spectrophotometry. The mixture was evaporated and the crude product
was chromatographed on a silica gel column eluted with 50% acetone/CH2Cl2 to afford 26.6
mg, 0.040 mmol, 48% yield of 131-(2-hydroxyethyl)amide-152,173-dimethyl ester chlorin e6
(14) (C38H45N5O6); mp 110–115 °C. UV-vis (MeOH): λmax, nm (ε) 399 (95,400), 499
(10,600), 526 (3,900), 556 (2,800), 607 (4,900), 661 (34,500). 1H NMR [(CD3)2CO, 400
MHz]: δ, ppm 9.82 (s, 1H), 9.77 (s, 1H), 9.12 (s, 1H), 8.26 (dd, J = 17.80, 11.52 Hz, 1H),
8.10 (br s, 1H), 6.43 (d, J = 17.84 Hz, 1H), 6.16 (d, J = 11.60 Hz, 1H), 5.67 (d, J = 19.16 Hz,
1H), 5.39 (d, J = 19.16 Hz, 1H), 4.67 (q, J = 7.12 Hz, 1H), 4.52 (d, J = 9.52, 1H), 4.09 (m,
1H), 4.02 (t, J = 5.72 Hz, 2H), 3.94 (m, 1H), 3.75 (s, 3H), 3.60 (s, 3H), 3.58 (s, 3H), 3.54 (s,
3H), 3.33 (s, 3H), 2.70 (m, 1H), 2.31 (m, 2H), 1.80 (m, 1H), 1.72 (d, J = 6.96, 3H), 1.71 (t, J
= 6.56, 3H), 1.60 (s, 1H), 1.29 (s, 1H), −1.58 (br s, 1H), −1.89 (br s, 1H). 13C NMR
[(CD3)2CO, 100 MHz]: δ, ppm 174.0, 170.2, 169.9, 168.7, 154.6, 150.0, 145.4, 139.3,
137.0, 136.4, 135.8, 135.2, 135.0, 130.9, 130.8, 130.3, 121.9, 104.1, 101.7, 99.4, 94.8, 69.7,
61.9, 55.5, 54.1, 52.3, 51.7, 49.7, 44.1, 38.1, 23.5, 19.9, 18.1, 12.3, 11.9, 11.2. HRMS
(MALDI-TOF): m/z 668.329 [M + H]+, calcd. for C38H46N5O6 668.345.
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131,152-Bis(2-hydroxyethyl)amide-chlorin e6 173-methyl ester (15)—The N-(2hydroxyethyl)acetamide pheophorbide a (16; 38.0 mg, 0.060 mmol, 1.0 equiv.) was
dissolved in toluene (5 mL) and ethanolamine (0.018 mL, 0.299 mmol, 5.0 equiv.) was
added. The reaction mixture was heated at 40 °C overnight. After the reaction was complete
by TLC, the solvent was removed and the residue was dissolved in CH2Cl2 and washed with
5% aqueous citric acid to remove excess amine, followed by a wash with brine. The organic
phase was dried over anhydrous Na2SO4 and the solvent was evaporated. The residue was
dissolved in 50:50 acetone/CH2Cl2 and purified via silica gel column chromatography to
afford 131,152-bis(2-hydroxyethyl)amide-chlorin e6 173-methyl ester (15, C39H41N6O6,
19.7 mg, 0.028 μMol, 47%); mp 135–140 °C. UV-vis (MeOH): λmax, nm (e) 399 (97,900),
499 (8,800), 527 (2,000), 556 (600), 608 (2,500), 661 (33,700). 1H NMR (acetone-d6, 400
MHz): δ, ppm 9.79 (s, 1H), 9.76 (s, 1H), 9.12 (s, 1H), 8.37 (br. s, 1H), 8.25 (dd, J = 17.8,
11.6 Hz, 1H), 6.97 (br. s, 1H), 6.42 (d, J = 17.8, 1H), 6.15 (d, J = 11.5 Hz, 1H), 5.55 (d, J =
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18.5 Hz, 1H), 5.19 (d, J = 17.9 Hz, 1H), 4.69–4.58 (m, 2H), 4.15 (s, 1H), 4.02 (br s, 2H),
3.95–3.88 (m, 1H), 3.84–3.76 (m, 4H), 3.31 (s, 3H), 2.81 (s, 3H), 2.72–2.65 (m, 1H), 2.60
(s, 3H), 2.37–2.27 (m, 2H), 1.74 (d, J = 7.2 Hz, 3H), 1.70 (t, J = 7.5 Hz, 3H), −1.61 (s, 1H),
−1.96 (s, 1H). 13C NMR [(CD3)2CO, 100 MHz]: δ, ppm 174.0, 170.3, 170.1, 168.9, 154.7,
150.0, 145.5, 139.3, 137.0, 136.2, 136.0, 135.2, 135.0, 131.0, 130.9, 130.3, 122.0, 104.2,
101.7, 99.4, 94.9, 69.7, 61.7, 61.3, 55.5, 54.0, 51.7, 44.3, 43.2, 40.6, 23.3, 19.9, 18.1, 12.3,
11.9, 11.3. MS (MALDI-TOF): m/z 697.333 [M + H]+, calcd. for C39H49N6O6 697.364.
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152-[N-(2-Hydroxyethyl)acetamide]-pheophorbide a (16)—Methyl pheophorbide a
(13) (51.3 mg, 0.085 mmol, 1.0 equiv.) was dissolved in dry toluene (5 mL) and the mixture
was heated to 100 °C under nitrogen. Then, ethanolamine (0.008 mL, 0.127 mmol, 1.5
equiv.) was added. The reaction mixture was allowed to stir at 100 °C for 19 h while
monitoring by TLC. Then the solvent was removed and the residue was dissolved in CH2Cl2
and washed with 5% aqueous citric acid, followed by water and brine. The organic phase
was dried over anhydrous Na2SO4 and the solvent was evaporated. The residue was
dissolved in 50% acetone/CH2Cl2 and purified via silica gel column chromatography with
the same mobile phase to afford 152-[N-(2-hydroxyethyl) acetamide]-pheophorbide a (16,
C37H41N5O5, 44.0 mg, 0.069 mmol, 82%). UV-vis (MeOH): λmax, nm (ε) 399 (79,800),
500 (5,700), 531 (900), 556 (500), 608 (1,400), 663 (27,400). 1H NMR (acetone-d6, 400
MHz): δ, ppm 9.71 (s, 1H), 9.44 (s, 1H), 8.90 (s, 1H), 8.16–7.95 (m, 2H), 6.34 (d, J = 17.8
Hz, 1H), 6.24 (s, 1H), 6.17 (d, J = 11.5, 1H), 4.64–4.59 (m, 1H), 4.44 (d, J = 9.3, 1H), 3.69–
3.65 (m, 2H), 3.63 (s, 3H), 3.53 (s, 3H), 3.43 (d, J = 5.4 Hz, 3H), 3.18 (s, 3H), 2.72–2.64 (m,
2H), 2.42–2.37 (m, 1H), 2.27–2.20 (m, 1H), 1.83 (d, J = 7.3 Hz, 3H), 1.72–1.68 (m, 1H),
1.64 (t, J = 7.5 Hz, 3H), −1.60–1.86 (m, 2H). 13C NMR [(CD3)2CO, 100 MHz]: δ, ppm
174.3, 173.3, 169.5, 163.4, 155.6, 151.5, 150.4, 145.6, 142.3, 138.6, 136.8, 136.6, 136.3,
132.6, 130.3, 129.9, 122.8, 107.8, 104.7, 97.6, 94.5, 66.9, 62.1, 55.6, 52.2, 51.8, 50.9, 43.6,
23.5, 19.5, 17.7, 12.1, 11.9, 10.9. MS (MALDI-TOF): m/z 636.239 [M + H]+, calcd. for
C37H42N5O5 636.319.
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131-monolysyl-chlorin e6 trimethyl ester (17)—In a round bottom flask, chlorin e6
dimethyl ester [8] (18, 102 mg, 0.165 mmol) was dissolved in dry CH2Cl2. A mixture of
HOBt (24 mg, 0.18 mmol), TBTU (58 mg, 0.18 mmol), and DIEA (0.02 mL) in DMF was
added to the mixture and allowed to stir for 30 min. H-Lys(Boc)-OMe hydrochloride (60
mg, 0.21 mmol) and DIEA (0.02 mL) were mixed in CH2Cl2 and added to the reaction
mixture. The mixture was allowed to stir for approximately 48 h and monitored using TLC.
Then, it was diluted with DCM, washed with 5.0% citric acid, followed by a wash with
water then with brine. The mixture was then dried over Na2SO4 and evaporated. The residue
was dissolved in 5.0% acetone/CH2Cl2 and purified via silica column chromatography with
the same mobile phase, to give the Boc-protected derivative (19). 1H NMR (CD3)2CO: δ,
ppm 9.75 (s, 1H), 9.71 (s, 1H), 9.12 (s, 1H), 8.51 (d, 1H), 8.20 (dd, 1H), 6.38 (d, 1H), 6.11
(d, 1H), 6.00 (br s, 1H), 5.75 (d, 1H), 5.24 (d, 1H), 4.95 (q, 1H), 4.67 (q, 1H), 4.49 (d, 1H),
3.97 (s, 3H), 3.74 (s, 3H), 3.73 (q, 2H), 3.64 (s, 3H), 3.61 (s, 3H), 3.51 (s, 3H), 3.27 (s, 3H),
3.16 (q, 2H), 2.72 (m, 1H), 2.30 (m, 2H), 2.10 (m, 1H), 1.72 (d, 3H), 1.70 (m, 5H), 1.68 (t,
3H), 1.46 (m, 1H), 1.28 (s, 9H), −1.60 (s, 1H), −1.90 (s, 1H). In a round bottom flask, the
Boc-protected chlorin e6 derivative (19) was dissolved in 5.0 mL of dry DCM in an ice bath
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under argon. Thioanisole (0.01 mL) and TFA (5.0 mL) were added and stirred overnight.
Then, the reaction mixture was diluted with CH2Cl2 and washed with water and 10%
NaHCO3 then dried over Na2SO4. The solvent was removed through rotary evaporation. The
residue was dissolved in 10% acetone/CH2Cl2 and purified via silica column
chromatography with the same mobile phase. This produced the title compound (17) in
overall 33% yield (43.5 mg, 0.057 mmol) starting from chlorin e6 (1). 1H NMR (CD3)2CO:
d, ppm 9.75 (s, 1H), 9.70 (s, 1H), 9.11 (s, 1H), 8.60 (d, 1H), 8.19 (dd, 1H), 6.37 (d, 1H),
6.10 (d, 1H), 5.75 (d, 1H), 5.24 (d, 1H), 4.95 (br s, 1H), 4.67 (q, 1H), 4.49 (d, 1H), 3.96 (s,
3H), 3.74 (s, 3H), 3.73 (q, 2H), 3.63 (s, 3H), 3.61 (s, 3H), 3.50 (s, 3H), 3.26 (s, 3H), 2.76 (m,
3H), 2.38 (m, 4H), 1.75 (m, 5H) 1.72 (d, 3H), 1.68 (t, 3H), 1.47 (m, 1H), 1.28 (m, 1H) −1.60
(s, 1H), −1.90 (s, 1H). MS (MALDI-TOF): m/z 767.437 [M + H]+, calcd. for C43H55N6O7
767.414.
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Cell studies
The HEp2 cell line used in this study was purchased from ATCC. The cells were cultured in
the medium (DMEM: AMEM = 1:1) containing 10% FBS and 1% antibiotic (Penicillinstreptomycin), and sub-cultured twice weekly to maintain sub-confluent stocks. All reagents
and culture medium were purchased from Life Technologies. A 32 mM compound stock
solution was prepared by dissolving the compound in DMSO (Sigma-Aldrich). All
compound working solutions were prepared by diluting the 32 mM stock solution with
culture medium.
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Dark toxicity—HEp2 cells were plated in a Costar 96-well plate (BD biosciences) 15000
cells per well and grown until the cell was getting 100% confluence. Subsequently, the cell
was treated with the compound concentration of 100, 50, 25, 12.5, 6.25, 3.125, 1.5625 and 0
μM, five repetitions for each concentration, and then incubated overnight at 37 °C. After 20–
24 h incubation, the compound was removed by washing cells with 1X PBS and replaced
with the media containing 20% cell titer blue. The cells were incubated for an additional 4 h
at 37 °C. The viable cells is measured fluorescently at 570/615 nm using a FluoStar Optima
micro-plate reader (BMG LABTECH). The dark toxicity was expressed in terms of the
percentage of viable cells.
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Phototoxicity—HEp2 cells were placed in a 96-well plate as above. Whenever the cell get
100% confluence it was treated with compound at the concentration range of 20, 10, 5, 2.5,
1.25, 0.625, 0.3125, 0.15625, and 0 μM for 24 h at 37 °C. After 24 h treatment, the loading
media was removed. The cells were washed with media, and then refill fresh media. The
cells were exposed to a 600 W halogen lamp light source filtered with a water filter and a
beam turning mirror 200 nm–3 μM (Newport) for 20 min. The total light dose was
approximately 1.5 J/cm2. After exposed to light, the cell was returned back to incubator for
another 24 h. The medium was removed and replaced with the media containing 20% cell
titer blue. The cells were incubated for an additional 4 h. The viable cells is measured
fluorescently at 570/615 nm using a FluoStar Optima micro-plate reader. As for the dark
toxicity, the phototoxicity was expressed in terms of the percentage of viable cells.
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Time-dependent cellular uptake—As described before, HEp2 cells were placed in 96
well plates, and grown for overnight, and then treated by adding 10 μM working solution
100 μL/well at different time periods of 0, 1, 2, 4, 8, and 24 h. The loading medium was
removed at the end of the treatments. The cells were washed with 1X PBS, and solubilized
by adding 0.25% Triton X-100 in 1X PBS. A compound standard curve, 10 μM, 5 μM, 2.5
μM, 1.25 μM, 0.625 μM, 0.3125 μM, was made by diluting 400 μM compound solution with
0.25% Triton X-100 (Sigma-Aldrich) in 1X PBS. A cell standard curve was prepared using
10000, 20000, 40000, 60000, 80000, and 100000 cells per well. The cells were quantified by
CyQuant Cell Proliferation Assay (Life Technologies). The compound and cell number were
determined using a FluoStar Optima micro-plate reader with wavelengths 680/700 nm for
compounds and 485/520 nm for cells, respectively. Cellular uptake was expressed in terms
of nM compound per cell.
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Microscopy—The subcellular fluorescence experiments were performed by culturing the
cells in a 6-well plate (Celltreat) with 10 μM concentration compound solution at 37 °C for 6
h. Afterwards, the medium was removed and cells were washed with 1X PBS three times.
Images were acquired using a Leica DMRXA2 microscope with a water immersion
objective and DAPI, GFP, and TRITC filter cubes (Chroma Technologies).

CONCLUSION

Author Manuscript

A series of chlorin e6 conjugates bearing one or two substituents on the 131 and/or 152
positions were synthesized and investigated for their cellular uptake, intracellular
localization and toxicity using human HEp2 cells. All compounds efficiently accumulated
within cells to a larger extent than chlorin e6, particularly the 152-substituted derivatives,
about 4–20 fold higher than chlorin e6 at 24 h. The in vitro cytotoxicity experiments reveal
that the 131-conjugates are much more toxic than the 152-conjugates, with the most toxic
derivative being the 131-ethylenediamine conjugate 11. The most useful PDT
photosentitizers appear to be the ethanolamine derivatives, 14 and 15, which are conjugated
at the 152-and the 131,152-positions due to their high phototoxicity but low dark toxicity
compared with 11.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.

Time-dependent uptake of chlorin e6 (1, orange) and its derivatives 7 (blue), 8 (yellow), 9
(red), 10 (green), 14 (brown) and 15 (purple) at 10 μM by HEp2 cells
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Fig. 2.
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The fluorescence of select chlorin e6 derivatives in HEp2 cells at 10 μM for 6 h; (a) 152(Bz)Ce6 DME (7), (b) 152-(nPr)Ce6 DME (8), (c) 152-(iPr)Ce6 DME (9), (d) 152-(EA)Ce6
DME (10), (e) 131-(EDA)Ce6 DME (11), and (f) 131,152-di(EDA)Ce6 ΜME (12). Scale bar:
10 μM
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Scheme 1.
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Syntheses of the 152-monoconjugates 7–10 from chlorin e6 (1) via the anhydride 5
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Scheme 2.
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Synthesis of the 131-ethylenediamine- 11 [9], 131,152-ethylenediamine 12 [12] and 131ethanolamine-conjugated ester derivatives 14 from methyl pheophorbide a (13)
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Scheme 3.

Synthesis of 131,152-bis-ethanolamine conjugate (15) from methyl pheophorbide a (13)
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Scheme 4.

Synthesis of 131-lysylchlorin e6 trimethyl ester (17) from chlorin e6 (1)
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Chart 1.

Structures of key chlorin e6 compounds
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Dark and phototoxicity (~1.5 J/cm2) for chlorin e6 and its derivatives in human HEp2 cells, using a Cell Titer
Blue assay
Compound

Dark toxicity (IC50, μM)

Phototoxicity (IC50, μM)

Ratio

12.9

>8

Chlorin e6 (1)

>100

152-(Bz)Ce6 DME (7)

>100

>50

>2

152-(nPr)Ce6 DME (8)

>100

1.54

>65

152-(iPr)Ce6 DME (9)

>100

1.31

>76

152-(EA)Ce6 DME (10)

>100

1.1

>91

0.23

30

131-(EDA)Ce6 DME (11)

7
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131,152-di(EDA)Ce6 ΜME (12)

45

1.23

37

131-(EA)Ce6 DME (14)

36

0.46

78

131,152-di(EA)Ce6 DME (15)

59

0.31

190

131-LysCe6 TME (17)

34

0.62

55
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